3Wada T,Furuichi K, Sakai N, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int ,2000,58 (4) : 1492-1499.
4Wang J , Li F,Calhoum JH,et al. The role and effectiveness of adjunctive hyperbaric oxygen in the management of musculoskeletal disorders. J Postgrad Med, 2002,48 ( 3 ) : 226 - 231.
5Marrugat J, Subirana I, Comin E, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health, 2007, 61 ( 1 ) :40-47.
6] Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in human. Circulation, 2005,111 (7) :932- 939.
4Denzi LM, Wilson SC, Michael MG. Secondary pulmonary hypertension in chronic heart failure : the role of the endothelium inpathophysiology and management. Circulation ,2000,102 ( 14 ) : 1718-1723.
5Keith IM. The role of endogenous lung neuropeptid regulation of the pulmonary circulation. Physiol Res, 2000, 49(5) : 519-537.
6Hurairah H, Ferro A. The role of the endothelium in the control of vascular function. Int J Clin Pract, 2004, 59(3) : 251-253.
7Vanhoutte PM. Endothelial control of vasomotor function from health to coronary disease. Circulation, 2003, 67(4) : 572-575.
8[1]Lunchner A,Muders F,Dietl O,et al.Differential Expression of Cardial ANP and BNP in a Rabbit Model of Progressive Left Ventricular Dysfunction[J].Cardiovsc Res,2001,51(30):601～607.
9[2]Berger R,Huels man M,Stree Rer K,et al.Type Natriuretic Peptide Predicts Sudden Death in Patients with Chronic Heart Failure[J].Circulation,2002,105(20):2392～2397.
10[3]Kawai K,Hatak,Takaoka H,et al.Plasma Brain Natriuretic Peptide as a Novel the Rapeutic Indicator in Idiopathic Dilated Cardiomyopathy during b-blocker Therapy:A Potential of Hormore-guied Treatment[J].Am Heart J,2001,141(6):925～932.
